Trial Profile
A study investigating the effect sunitinib and gene expression associated with sunitinib in patients with clear cell renal cell carcinoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2015
Price :
$35
*
At a glance
- Drugs Sunitinib (Primary)
- Indications Renal cell carcinoma
- Focus Pharmacodynamics
- 19 Dec 2015 New trial record